Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3089)
All Articles published online
|
Jan 14, 2008 (publication date) through Dec 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ayaz C, Celen MK, Yuce UN, Geyik MF. Efficacy and safety of pegylated-interferon α-2a in hemodialysis patients with chronic hepatitis C. World J Gastroenterol 2008; 14(2): 255-259 [PMID: 18186564 DOI: 10.3748/wjg.14.255] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i2/255.htm |
| Number | Citing Articles |
| 1 |
Attur Ravindra Prabhu, Indu Ramachandra Rao, Shankar Prasad Nagaraju, Eti Rajwar, Bhumika T Venkatesh, Sreekumaran Nair N, Ganesh Pai, Nageswara P Reddy, Deepak Suvarna. Interventions for dialysis patients with hepatitis C virus (HCV) infection. Cochrane Database of Systematic Reviews 2023; 2023(4) doi: 10.1002/14651858.CD007003.pub3
|
| 2 |
Sang Bong Ahn, Dae Won Jun, Sang Gyune Kim, Sae Hwan Lee, Hyun Phil Shin, Won Hyeok Choe, Ja Kyung Kim, Kyu Sik Jung, Do Young Kim, Jae-Jun Shim, Soo Young Park, Yeon Seok Seo, Won Kim, Jae Il Chung. Efficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis. European Journal of Internal Medicine 2015; 26(4): 292 doi: 10.1016/j.ejim.2015.03.011
|
| 3 |
Fabrizio Fabrizi, Vivek Dixit, Piergiorgio Messa, Paul Martin. Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta‐analysis of clinical trials. Journal of Medical Virology 2010; 82(5): 768 doi: 10.1002/jmv.21542
|
| 4 |
Goki Suda, Naoya Sakamoto. Recent advances in the treatment of hepatitis C virus infection for special populations and remaining problems. Journal of Gastroenterology and Hepatology 2021; 36(5): 1152 doi: 10.1111/jgh.15189
|
| 5 |
Fabrizio Fabrizi, Piergiorgio Messa, Carlo Basile, Paul Martin. Hepatic disorders in chronic kidney disease. Nature Reviews Nephrology 2010; 6(7): 395 doi: 10.1038/nrneph.2010.37
|
| 6 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2008; 17(8) doi: 10.1002/pds.1489
|
| 7 |
Fabrizio Fabrizi, Vivek Dixit, Piergiorgio Messa, Paul Martin. Pegylated Interferon Mono‐Therapy of Chronic Hepatitis C in the Dialysis Population: Systematic Review and Meta‐Analysis. Therapeutic Apheresis and Dialysis 2015; 19(6): 611 doi: 10.1111/1744-9987.12318
|
| 8 |
Paul Martin, Fabrizio Fabrizi. Hepatitis C virus and kidney disease. Journal of Hepatology 2008; 49(4): 613 doi: 10.1016/j.jhep.2008.06.003
|
| 9 |
Marco Carbone, Paul Cockwell, James Neuberger. Hepatitis C and Kidney Transplantation. International Journal of Nephrology 2011; 2011: 1 doi: 10.4061/2011/593291
|
| 10 |
Goki Suda, Koji Ogawa, Kenichi Morikawa, Naoya Sakamoto. Treatment of hepatitis C in special populations. Journal of Gastroenterology 2018; 53(5): 591 doi: 10.1007/s00535-017-1427-x
|
| 11 |
Anaïs Vallet-Pichard, Stanislas Pol. Prise en charge de l’infection par les virus des hépatites B ou C chez l’insuffisant rénal chronique. Néphrologie & Thérapeutique 2015; 11(6): 507 doi: 10.1016/j.nephro.2015.06.002
|
| 12 |
Şükran Köse, Süheyla Serin Senger, Gürsel Ersan, Gülsün Çavdar. Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C. Clinical and Experimental Nephrology 2013; 17(1): 115 doi: 10.1007/s10157-012-0663-x
|
| 13 |
Hossein Ghaderi-Zefrehi, Mohammad Gholami-Fesharaki, Heidar Sharafi, Farzin Sadeghi, Seyed Moayed Alavian. The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepatitis Monthly 2016; 16(9) doi: 10.5812/hepatmon.40357
|
| 14 |
Ravindra A Prabhu, Sreekumar Nair, Ganesh Pai, Nageswara P Reddy, Deepak Suvarna. Interventions for dialysis patients with hepatitis C virus (HCV) infection. Cochrane Database of Systematic Reviews 2015; 2015(8) doi: 10.1002/14651858.CD007003.pub2
|
| 15 |
Takashi Akiba, Kazuhiko Hora, Michio Imawari, Chifumi Sato, Eiji Tanaka, Namiki Izumi, Takashi Harada, Ryoichi Ando, Kan Kikuchi, Tadashi Tomo, Hideki Hirakata, Tadao Akizawa. 2011 Japanese Society for Dialysis Therapy Guidelines for the Treatment of Hepatitis C Virus Infection in Dialysis Patients. Therapeutic Apheresis and Dialysis 2012; 16(4): 289 doi: 10.1111/j.1744-9987.2012.01078.x
|
| 16 |
Fabrizio Fabrizi, Paul Martin. Health Care–Associated Transmission of Hepatitis B and C Viruses in Hemodialysis Units. Clinics in Liver Disease 2010; 14(1): 49 doi: 10.1016/j.cld.2009.11.011
|
| 17 |
Alan Gunderson, Adnan Said. Liver disease in kidney transplant recipients. Transplantation Reviews 2015; 29(1): 1 doi: 10.1016/j.trre.2014.08.002
|
| 18 |
Chen‐Hua Liu, Jia‐Horng Kao. Treatment of hepatitis C virus infection in patients with end‐stage renal disease. Journal of Gastroenterology and Hepatology 2011; 26(2): 228 doi: 10.1111/j.1440-1746.2010.06488.x
|
| 19 |
Ayla Gokmen, Yucel Ustundag, Nefise Oztoprak, Selim Aydemir, Ishak Ozel Tekin, Basak Cakal, Sibel Kiran, Huseyin Engin. Effects of Pegylated Interferon α on Fibrinolytic Parameters in Patients With Chronic Hepatitis C. Clinical and Applied Thrombosis/Hemostasis 2011; 17(5): 449 doi: 10.1177/1076029610371475
|
| 20 |
Bruno Pozzetto, Meriam Memmi, Olivier Garraud, Xavier Roblin, Philippe Berthelot. Health care-associated hepatitis C virus infection. World Journal of Gastroenterology 2014; 20(46): 17265-17278 doi: 10.3748/wjg.v20.i46.17265
|
| 21 |
Fabrizio Fabrizi, Paul Martin. Clinical Dilemmas in Viral Liver Disease. 2010; : 50 doi: 10.1002/9781444319590.ch11
|
| 22 |
Goki Suda, Mineo Kudo, Atsushi Nagasaka, Ken Furuya, Yoshiya Yamamoto, Tomoe Kobayashi, Keisuke Shinada, Miki Tateyama, Jun Konno, Yoko Tsukuda, Kazushi Yamasaki, Megumi Kimura, Machiko Umemura, Takaaki Izumi, Seiji Tsunematsu, Fumiyuki Sato, Katsumi Terashita, Masato Nakai, Hiromasa Horimoto, Takuya Sho, Mitsuteru Natsuizaka, Kenichi Morikawa, Koji Ogawa, Naoya Sakamoto. Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C. Journal of Gastroenterology 2016; 51(7): 733 doi: 10.1007/s00535-016-1162-8
|
| 23 |
N. Kamar, F. Abravanel, C. Garrouste, I. Cardeau-Desangles, J. M. Mansuy, H. Weclawiak, J. Izopet, L. Rostaing. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrology Dialysis Transplantation 2010; 25(8): 2792 doi: 10.1093/ndt/gfq282
|
| 24 |
Chrisoula Pipili, George Ilonidis, Evangelos Cholongitas. Hepatitis C virus and kidney: a strong association with different clinical aspects. Liver International 2011; 31(8): 1071 doi: 10.1111/j.1478-3231.2011.02458.x
|
| 25 |
Julio A. Gutierrez, Heather M. Patton. Hepatitis C Virus and End Stage Renal Disease. Current Hepatitis Reports 2011; 10(3): 196 doi: 10.1007/s11901-011-0104-4
|
| 26 |
|
| 27 |
Norberto C. Chávez-Tapia, Ezequiel Ridruejo, Angelo Alves de Mattos, Fernando Bessone, Jorge Daruich, Juan F. Sánchez-Ávila, Hugo Cheinquer, Rodrigo Zapata, Misael Uribe, Francisco Bosques-Padilla, Adrián Gadano, Alejandro Soza, Milagros Dávalos-Moscol, Claudio Marroni, Linda Muñoz-Espinoza, Graciela Castro-Narro, Raymundo Paraná, Nahum Méndez-Sánchez. An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver. Annals of Hepatology 2013; 12: S3 doi: 10.1016/S1665-2681(19)31404-8
|
| 28 |
Samir Mohindra, Narayan Prasad. Treatment of hepatitis C in renal failure. Clinical Queries: Nephrology 2012; 1(3): 236 doi: 10.1016/j.cqn.2012.06.004
|
| 29 |
A. Covic, D. Abramowicz, A. Bruchfeld, G. Leroux-Roels, D. Samuel, W. van Biesen, C. Zoccali, F. Zoulim, R. Vanholder. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement. Nephrology Dialysis Transplantation 2008; 24(3): 719 doi: 10.1093/ndt/gfn608
|
| 30 |
Aline Gonzalez Vigani. Hepatitis C infection and chronic renal diseases. Hepatology International 2013; 7(1): 16 doi: 10.1007/s12072-012-9356-5
|
| 31 |
A. Vallet-Pichard, S. Pol. Prise en charge de l’infection par les virus des hépatites B ou C chez l’insuffisant rénal chronique. EMC - Néphrologie 2012; 9(4): 1 doi: 10.1016/S1762-0945(12)58277-X
|
| 32 |
Fabrizio Fabrizi, Alessio Aghemo, Piergiorgio Messa. Hepatitis C treatment in patients with kidney disease. Kidney International 2013; 84(5): 874 doi: 10.1038/ki.2013.264
|